Exemestane
NDC 68382-383, Exemestane, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-383
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202602
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-383 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EXEMESTANE25 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-383-06 | 68382038306 | 30 TABLET in 1 BOTTLE (68382-383-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f1bbe1bd-fa92-4fdd-88df-31ebcb200d37NADAC price for package 68382038306
GET /v1/drugs/nadac/68382038306
Use it
Look up 68382-383 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-383 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-383. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.